United States

People: Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

4:00pm EDT
Change (% chg)

$-0.04 (-4.19%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kennedy, Timothy 

Mr. Timothy C. Kennedy is Chief Financial Officer, Senior Vice President of Operations, Corporate Secretary of the Company. Mr. Kennedy has over 30 years of executive, financial, and operational leadership experience, with over 25 years in the clinical diagnostics industry. Mr. Kennedy previously served as Chief Financial Officer of Millennium Health, a privately held leading urine drug testing and pharmacogenetics laboratory company, from 2013 to July 2016. Prior to joining Millennium Health, Mr. Kennedy was Chief Financial Officer and General Manager of PLUS Diagnostics, a urology, gastroenterology and oncology lab from 2008 through 2012. Prior to Plus Diagnostics, Mr. Kennedy held an ownership position in Diagnostic Imaging Management, a multi-site imaging company from 1997 to 2008, expanding from 12 to 33 free-standing centers across the United States. From 1988 to 1997, Mr. Kennedy held a number of management positions with National Health Laboratories, where he served as the Head of Finance, completing over 50 acquisitions and the merger with Roche Biomedical Labs to form LabCorp in 1995. Mr. Kennedy serves on the Board of Directors of MyCircle Health, a data services company that helps patients with chronic health conditions measure, evaluate, control and communicate daily test results to their healthcare providers and physicians. Mr. Kennedy holds a bachelor’s degree in Business - Accounting/Information Technology from Keane University.

Basic Compensation

Total Annual Compensation, USD 393,319
Restricted Stock Awards, USD 75,000
Long-Term Incentive Plans, USD --
All Other, USD 154,118
Fiscal Year Total, USD 622,437

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Hale


Michael Nall


Timothy Kennedy


Lyle Arnold


Edwin Hendrick


Michael Terry

As Of  30 Dec 2017